259 related articles for article (PubMed ID: 3757903)
1. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
Gallagher JA; Beneton M; Harvey L; Lawson DE
Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
[TBL] [Abstract][Full Text] [Related]
2. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat.
Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M
Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
Kraft D; Offermann G; Steldinger R; Gawlik D
Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
[TBL] [Abstract][Full Text] [Related]
4. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice.
Ono T; Tanaka H; Yamate T; Nagai Y; Nakamura T; Seino Y
Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218
[TBL] [Abstract][Full Text] [Related]
5. Effects of vitamin D metabolites on healing of low phosphate, vitamin D-deficient induced rickets in rats.
Atkin I; Pita JC; Ornoy A; Agundez A; Castiglione G; Howell DS
Bone; 1985; 6(2):113-23. PubMed ID: 3874635
[TBL] [Abstract][Full Text] [Related]
6. Histological observations on the failure of rachitic rat bones to respond to 1,25/OH)2D3.
Gallagher JA; Lawson DE
Calcif Tissue Int; 1980; 31(3):215-23. PubMed ID: 6258762
[TBL] [Abstract][Full Text] [Related]
7. The effect of vitamin D on bone in vivo.
Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
[TBL] [Abstract][Full Text] [Related]
8. Modulation of renal production of 24,25- and 1,25-dihydroxyvitamin D3 in young and adult rats by dietary calcium, phosphorus, and 1,25-dihydroxyvitamin D3.
Armbrecht HJ; Zenser TV; Davis BB
Endocrinology; 1982 Jun; 110(6):1983-8. PubMed ID: 6978809
[TBL] [Abstract][Full Text] [Related]
9. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
Safadi FF; Hermey DC; Popoff SN; Seifert MF
Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
[TBL] [Abstract][Full Text] [Related]
10. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. The dichotomy in the effects of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats.
Wientroub S; Price PA; Reddi AH
Calcif Tissue Int; 1987 Mar; 40(3):166-72. PubMed ID: 3105848
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats.
Vukicević S; Krempien B; Stavljenić A
J Bone Miner Res; 1987 Dec; 2(6):533-45. PubMed ID: 3502683
[TBL] [Abstract][Full Text] [Related]
14. Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats.
Lian JB; Carnes DL; Glimcher MJ
Endocrinology; 1987 May; 120(5):2123-30. PubMed ID: 3494594
[TBL] [Abstract][Full Text] [Related]
15. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
Goodman WG; Baylink DJ; Sherrard DJ
Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
Finch JL; Brown AJ; Slatopolsky E
J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
[TBL] [Abstract][Full Text] [Related]
18. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
19. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
Marie PJ; Travers R; Glorieux FH
Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
[TBL] [Abstract][Full Text] [Related]
20. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
